Abstract
Background: The impact of preoperative glycemic control on the survival outcomes of patients undergoing a radical hysterectomy (RH) for cervical cancer has not been investigated. Patients and Methods: We reviewed patients who underwent a type III RH for cervical cancer between January 2004 and June 2011 in our institution. Results: A total of 431 patients were included and 83 (19.3%) were diagnosed with diabetes mellitus (DM). Poorly controlled DM (preoperative hemoglobin A1c [HbA1c] ≥7.0%) was observed in 49 (59.0%) diabetic patients. Compared to patients without DM and diabetic patients with good glycemic control (preoperative HbA1c <7.0%), diabetic patients with poor glycemic control had significantly higher risks of tumor recurrence, cervical cancer-specific death, and overall death. In multivariate analysis, DM with poor glycemic control independently predicted recurrence-free survival (RFS), cancer-specific survival (CSS), and overall survival (OS). We excluded patients without DM and performed a sensitivity analysis. When HbA1c levels were treated as a dichotomous variable, preoperative HbA1c ≥7.0% was independently associated with RFS, CSS, and OS. When HbA1c level was treated as a continuous variable, it remained an independent predictor of RFS, CSS, and OS. Conclusion: DM with poor glycemic control prior to RH was significantly associated with an increased risk of recurrence and mortality in cervical cancer patients. These results underscore the importance of intensive glycemic control and close follow-up for diabetic patients.
Journal Section:
Research Article
References
1.
Weng
J
, Pozzilli
P
. Hot topics on diabetes in China
. Diabetes Metab Res Rev
. 2015
Nov
;31
(8
):779
–80
.
[PubMed]
1520-75522.
Yang
SH
, Dou
KF
, Song
WJ
. Prevalence of diabetes among men and women in China
. N Engl J Med
. 2010
Jun
;362
(25
):2425
–6
.
[PubMed]
0028-47933.
Xu
T
. Chinese Anti-Cancer Association as a non-governmental organization undertakes systematic cancer prevention work in China
. Chin J Cancer Res
. 2015
Aug
;27
(4
):423
–7
.
[PubMed]
1000-96044.
Chen
W
, Zheng
R
, Zeng
H
, Zhang
S
. The incidence and mortality of major cancers in China, 2012
. Chin J Cancer
. 2016
Aug
;35
(1
):73
.
[PubMed]
1000-467X5.
Goss
PE
, Strasser-Weippl
K
, Lee-Bychkovsky
BL
, Fan
L
, Li
J
, Chavarri-Guerra
Y
, et al.. Challenges to effective cancer control in China, India, and Russia
. Lancet Oncol
. 2014
Apr
;15
(5
):489
–538
.
[PubMed]
1470-20456.
Koh
WJ
, Greer
BE
, Abu-Rustum
NR
, Apte
SM
, Campos
SM
, Cho
KR
, et al.. Cervical Cancer, Version 2.2015
[quiz]
. J Natl Compr Canc Netw
. 2015
Apr
;13
(4
):395
–404
.
[PubMed]
1540-14057.
Ko
C
, Chaudhry
S
. The need for a multidisciplinary approach to cancer care
. J Surg Res
. 2002
Jun
;105
(1
):53
–7
.
[PubMed]
0022-48048.
Li
J
, Wu
MF
, Lu
HW
, Zhang
BZ
, Wang
LJ
, Lin
ZQ
. Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer
. PLoS One
. 2016
Nov
;11
(11
):e0166612
.
[PubMed]
1932-62039.
Tai
YS
, Chen
CH
, Huang
CY
, Tai
HC
, Wang
SM
, Pu
YS
. Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma
. Diabetes Metab Res Rev
. 2015
Mar
;31
(3
):307
–14
.
[PubMed]
1520-755210.
Kaneda
K
, Uenishi
T
, Takemura
S
, Shinkawa
H
, Urata
Y
, Sakae
M
, et al.. The influence of postoperative glycemic control on recurrence after curative resection in diabetics with hepatitis C virus-related hepatocellular carcinoma
. J Surg Oncol
. 2012
May
;105
(6
):606
–11
.
[PubMed]
0022-479011.
Lee
H
, Kuk
H
, Byun
SS
, Lee
SE
, Hong
SK
. Preoperative glycemic control status as a significant predictor of biochemical recurrence in prostate cancer patients after radical prostatectomy
. PLoS One
. 2015
Apr
;10
(4
):e0124761
.
[PubMed]
1932-620312.
Erickson
K
, Patterson
RE
, Flatt
SW
, Natarajan
L
, Parker
BA
, Heath
DD
, et al.. Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer
. J Clin Oncol
. 2011
Jan
;29
(1
):54
–60
.
[PubMed]
0732-183X13.
Siddiqui
AA
, Spechler
SJ
, Huerta
S
, Dredar
S
, Little
BB
, Cryer
B
. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study
. Dig Dis Sci
. 2008
Sep
;53
(9
):2486
–94
.
[PubMed]
0163-211614.
Sarma
AV
, Hotaling
J
, Dunn
RL
, Cleary
PA
, Braffett
BH
, Kim
C
, et al.; DCCT/EDIC Research Group
. Poor glycemic control is associated with reduced prostate specific antigen concentrations in men with type 1 diabetes
. J Urol
. 2015
Mar
;193
(3
):786
–93
.
[PubMed]
0022-534715.
Lee
YY
, Choi
CH
, Kim
CJ
, Song
TJ
, Kim
MK
, Kim
TJ
, et al.. Glucose as a prognostic factor in non-diabetic women with locally advanced cervical cancer (IIB-IVA)
. Gynecol Oncol
. 2010
Mar
;116
(3
):459
–63
.
[PubMed]
0090-825816.
Nomelini
RS
, Neto
AS
, Capuci
KA
, Murta
BM
, Murta
EF
. Relationship between plasma glucose levels and malignant uterine cervical neoplasias
. Clin Med Insights Oncol
. 2011
;5
:77
–82
.
[PubMed]
1179-554917.
In Choi
J
, Chang
HK
, Lee
DW
, Lee
KH
, Park
JS
, Lee
HN
. Does diabetes mellitus have an impact on the prognosis for patients with cervical cancer
. Gynecol Oncol
. 2015
Nov
;139
(2
):319
–23
.
[PubMed]
0090-825818.
American Diabetes Association
. Diagnosis and classification of diabetes mellitus
. Diabetes Care
. 2014
Jan
;37
Suppl 1
:S81
–90
.
[PubMed]
0149-599219.
Yu
NC
, Su
HY
, Chiou
ST
, Yeh
MC
, Yeh
SW
, Tzeng
MS
, et al.. Trends of ABC control 2006-2011: a National Survey of Diabetes Health Promotion Institutes in Taiwan
. Diabetes Res Clin Pract
. 2013
Feb
;99
(2
):112
–9
.
[PubMed]
0168-822720.
Yu
S
, Yang
CS
, Li
J
, You
W
, Chen
J
, Cao
Y
, et al.. Cancer Prevention Research in China
. Cancer Prev Res (Phila)
. 2015
Aug
;8
(8
):662
–74
.
[PubMed]
1940-620721.
Shi
JF
, Canfell
K
, Lew
JB
, Qiao
YL
. The burden of cervical cancer in China: synthesis of the evidence
. Int J Cancer
. 2012
Feb
;130
(3
):641
–52
.
[PubMed]
0020-713622.
Hanahan
D
, Weinberg
RA
. Hallmarks of cancer: the next generation
. Cell
. 2011
Mar
;144
(5
):646
–74
.
[PubMed]
0092-867423.
Day
RT
, Cavaglieri
RC
, Tabatabaimir
H
, Mantravadi
V
, Lee
MJ
, Barnes
JL
, et al.. Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2)
. Cell Signal
. 2010
Dec
;22
(12
):1849
–57
.
[PubMed]
0898-656824.
Ishizuka
T
, Hinata
T
, Watanabe
Y
. Superoxide induced by a high-glucose concentration attenuates production of angiogenic growth factors in hypoxic mouse mesenchymal stem cells
. J Endocrinol
. 2011
Feb
;208
(2
):147
–59
.
[PubMed]
0022-079525.
Giovannucci
E
. Insulin, insulin-like growth factors and colon cancer: a review of the evidence
. J Nutr
. 2001
Nov
;131
(11
Suppl
):3109S
–20S
.
[PubMed]
0022-316626.
Krone
CA
, Ely
JT
. Controlling hyperglycemia as an adjunct to cancer therapy
. Integr Cancer Ther
. 2005
Mar
;4
(1
):25
–31
.
[PubMed]
1534-735427.
Coyle
C
, Cafferty
FH
, Vale
C
, Langley
RE
. Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
. Ann Oncol
. 2016
Dec
;27
(12
):2184
–95
.
[PubMed]
0923-753428.
Ko
EM
, Walter
P
, Jackson
A
, Clark
L
, Franasiak
J
, Bolac
C
, et al.. Metformin is associated with improved survival in endometrial cancer
. Gynecol Oncol
. 2014
Feb
;132
(2
):438
–42
.
[PubMed]
0090-825829.
Shank
JJ
, Yang
K
, Ghannam
J
, Cabrera
L
, Johnston
CJ
, Reynolds
RK
, et al.. Metformin targets ovarian cancer stem cells in vitro and in vivo
. Gynecol Oncol
. 2012
Nov
;127
(2
):390
–7
.
[PubMed]
0090-825830.
Currie
CJ
, Poole
CD
, Jenkins-Jones
S
, Gale
EA
, Johnson
JA
, Morgan
CL
. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival
. Diabetes Care
. 2012
Feb
;35
(2
):299
–304
.
[PubMed]
0149-599231.
Romero
IL
, McCormick
A
, McEwen
KA
, Park
S
, Karrison
T
, Yamada
SD
, et al.. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity
. Obstet Gynecol
. 2012
Jan
;119
(1
):61
–7
.
[PubMed]
0029-784432.
Hanprasertpong
J
, Jiamset
I
, Geater
A
, Peerawong
T
, Hemman
W
, Kornsilp
S
. The Effect of Metformin on Oncological Outcomes in Patients With Cervical Cancer With Type 2 Diabetes Mellitus
. Int J Gynecol Cancer
. 2017
Jan
;27
(1
):131
–7
.
[PubMed]
1048-891X33.
Han
K
, Pintilie
M
, Lipscombe
LL
, Lega
IC
, Milosevic
MF
, Fyles
AW
. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes
. Cancer Epidemiol Biomarkers Prev
. 2016
Mar
;25
(3
):507
–12
.
[PubMed]
1055-996534.
Wiebe
E
, Denny
L
, Thomas
G
. Cancer of the cervix uteri
. Int J Gynaecol Obstet
. 2012
Oct
;119
Suppl 2
:S100
–9
.
[PubMed]
0020-7292© 2019 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2019
You do not currently have access to this content.
